These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35504334)

  • 1. Wangzaozin A, a potent novel microtubule stabilizer, targets both the taxane and laulimalide sites on β-tubulin through molecular dynamics simulations.
    Yang MH; Mao J; Zhu JH; Zhang H; Ding L
    Life Sci; 2022 Jul; 301():120583. PubMed ID: 35504334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel microtubule stabilizers targeting taxane binding site by applying molecular docking, molecular dynamics simulation, and anticancer activity testing.
    Zhang H; Qi HZ; Mao J; Zhang HR; Luo QQ; Hu ML; Shen C; Ding L
    Bioorg Chem; 2022 May; 122():105722. PubMed ID: 35303622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
    Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
    J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
    Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
    Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of microtubule stabilization by laulimalide and peloruside A.
    Prota AE; Bargsten K; Northcote PT; Marsh M; Altmann KH; Miller JH; Díaz JF; Steinmetz MO
    Angew Chem Int Ed Engl; 2014 Feb; 53(6):1621-5. PubMed ID: 24470331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
    Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
    J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
    Gapud EJ; Bai R; Ghosh AK; Hamel E
    Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
    Tripathi S; Srivastava G; Sharma A
    Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of lateral and longitudinal interdimeric interactions in microtubule models by Laulimalide and Peloruside A association: A molecular modeling approach on the mechanism of microtubule stabilizing agents.
    Zúñiga MA; Alderete JB; Jaña GA; Fernandez PA; Ramos MJ; Jiménez VA
    Chem Biol Drug Des; 2018 May; 91(5):1042-1055. PubMed ID: 29316292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol.
    Clark EA; Hills PM; Davidson BS; Wender PA; Mooberry SL
    Mol Pharm; 2006; 3(4):457-67. PubMed ID: 16889440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.
    Yadava U; Gupta H; Roychoudhury M
    J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments.
    Churchill CD; Klobukowski M; Tuszynski JA
    Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
    Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
    Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
    Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
    Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule-stabilizing agents based on designed laulimalide analogues.
    Mooberry SL; Randall-Hlubek DA; Leal RM; Hegde SG; Hubbard RD; Zhang L; Wender PA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8803-8. PubMed ID: 15161976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.
    Field JJ; Pera B; Calvo E; Canales A; Zurwerra D; Trigili C; Rodríguez-Salarichs J; Matesanz R; Kanakkanthara A; Wakefield SJ; Singh AJ; Jiménez-Barbero J; Northcote P; Miller JH; López JA; Hamel E; Barasoain I; Altmann KH; Díaz JF
    Chem Biol; 2012 Jun; 19(6):686-98. PubMed ID: 22726683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the binding mode of laulimalide to microtubules: Establishing a laulimalide-tubulin pharmacophore.
    Churchill CD; Klobukowski M; Tuszynski JA
    J Biomol Struct Dyn; 2016 Jul; 34(7):1455-69. PubMed ID: 26230757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
    Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
    Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.